Enliven Therapeutics, Inc. (ELVN)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
57. 86
-0.03
-0.0518%
After Hours
$
+2.11 +3.6467% 59. 97
4.14B Market Cap
- P/E Ratio
- Div Yield
1.04M Volume
-2.36 Eps
$ 57.89
Previous Close 
Want to track ELVN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Wall Street Analysts Think Enliven Therapeutics, Inc. (ELVN) Could Surge 43.04%: Read This Before Placing a Bet
The consensus price target hints at a 43% upside potential for Enliven Therapeutics, Inc. (ELVN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks | 2 years ago
